66 filings
Page 2 of 4
8-K
bcq76vio4 4nfdpmah
13 Mar 23
Regulation FD Disclosure
6:08am
8-K
2v2r2 5ybpuhl
20 Jan 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K
yoy6panl36yrw
12 Jan 23
Biora Therapeutics Receives Pre-IND Feedback from FDA and Provides Update on Key Programs for 2023
6:06am
8-K
dureb1a5sii2uzg4t5q
9 Jan 23
Material Modifications to Rights of Security Holders
4:02pm
8-K
9sr32lir aorix
30 Dec 22
Material Modifications to Rights of Security Holders
9:01am
8-K
vauhv4r
19 Dec 22
Submission of Matters to a Vote of Security Holders
4:20pm
8-K
1zasn 7sx
9 Dec 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm
8-K
5mpsx0o
28 Nov 22
Amendments to Articles of Incorporation or Bylaws
4:06pm
8-K
7p4gef m1xn0n8iq31g
23 Nov 22
Entry into a Material Definitive Agreement
4:06pm
8-K
rimjl71vl5lotabayec
14 Nov 22
Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2022 Financial Results
5:24pm
8-K
wmplgbu5m
10 Nov 22
Material Modifications to Rights of Security Holders
4:07pm
8-K
8sxksc 15c2i
9 Nov 22
Entry into a Material Definitive Agreement
4:50pm
8-K
gdexejoey3xha
15 Aug 22
Biora Therapeutics Provides Corporate Update and Reports Second Quarter 2022 Financial Results
4:18pm
8-K
7w9461
15 Jun 22
Submission of Matters to a Vote of Security Holders
5:00pm
8-K
q4ge01
10 Jun 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K
a9a9c sb87bxo4hml
10 May 22
Biora Therapeutics Provides Corporate Update and Reports First Quarter 2022 Financial Results
4:07pm
8-K
5gun7a bk
27 Apr 22
Amendments to Articles of Incorporation or Bylaws
4:09pm
8-K
pk8b7m6
28 Mar 22
Progenity Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results
4:05pm
8-K
nvzoy7f 54nm9p
17 Feb 22
Departure of Directors or Certain Officers
4:30pm
8-K
9rlh3 gi7vgi
20 Dec 21
Progenity Completes Exit from Laboratory Business with Sale of Affiliate Lab
4:15pm